Choice of Perioperative Anesthetic Medications in Patients Undergoing Bariatric Surgery.

Abstract:

:The prevalence of obesity is increasing globally. Rational perioperative anesthetic drug selection and administration require knowledge of how obesity interacts with those drugs. In this review, we summarize different aspects of the anesthetic agents, including pharmacokinetics (PK), pharmacodynamics (PD) and clinical application of the most commonly used medications with particular focus on the enhanced recovery of the obese patient.

journal_name

Curr Pharm Des

authors

Dos Reis Falcão LF,Mc Loughlin S,Alvarez A

doi

10.2174/1381612825666190628161206

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

2115-2122

issue

19

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-99302

journal_volume

25

pub_type

杂志文章,评审
  • Resting state abnormalities in psychosis compared to acute cannabinoids and opioids challenges: a systematic review of functional imaging studies.

    abstract::We conducted a systematic review on resting state cerebral blood flow activities found in first-episode psychosis (FEP) and during acute effects of cannabinoids and opioids, mental states that can be profoundly different from normal functioning. The main goal was to identify connections of cerebral blood flow measure ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212802884717

    authors: Denier N,Walter M,Bendfeldt K,Lang U,Borgwardt S

    更新日期:2012-01-01 00:00:00

  • Bioactivity Prediction Based on Matched Molecular Pair and Matched Molecular Series Methods.

    abstract:BACKGROUND:Enhancing a compound's biological activity is the central task for lead optimization in small molecules drug discovery. However, it is laborious to perform many iterative rounds of compound synthesis and bioactivity tests. To address the issue, it is highly demanding to develop high quality in silico bioacti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200427111309

    authors: Ding X,Cui C,Wang D,Zhao J,Zheng M,Luo X,Jiang H,Chen K

    更新日期:2020-01-01 00:00:00

  • New Approaches for Weight Loss: Experiments Using Animal Models.

    abstract::The number of people who are overweight and obese are continuously increasing both in the adult and adolescent populations. Coinciding with this is the increased prevalence of health problems such as type 2 diabetes (T2D). Bariatric surgery is the only proven long-term treatment of obesity and may induce remission of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180614075412

    authors: Olsen MK,Johannessen H,Ramracheya R,Zhao CM,Chen D

    更新日期:2018-01-01 00:00:00

  • Quantitative electroencephalogram (EEG) in insomnia: a new window on pathophysiological mechanisms.

    abstract::In the last two decades quantitative electroencephalogram (EEG) analysis has been widely used to investigate the neurophysiological characteristics of insomnia. These studies provided evidence in support of the hypothesis that primary insomnia is associated with hyperarousal of central nervous system and altered sleep...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786549326

    authors: Marzano C,Ferrara M,Sforza E,De Gennaro L

    更新日期:2008-01-01 00:00:00

  • Machine learning methods in prediction of protein palmitoylation sites: A brief review.

    abstract::Protein palmitoylation is a fundamental and reversible post-translational lipid modification that involves a series of biological processes. Although a large number of experimental studies have explored the molecular mechanism behind the palmitoylation process, the computational methods has attracted much attention fo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666201112142826

    authors: Li Y,Pu F,Wang J,Zhou Z,Zhang C,He F,Ma Z,Zhang J

    更新日期:2020-11-12 00:00:00

  • Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues.

    abstract::Many plant species and tissues have been investigated as production and delivery vehicles for recombinant pharmaceutical proteins. Examples include cultured cells, whole aquatic plants and transgenic plants expressing recombinant proteins in their leaves, seeds, fruits or tubers/roots. Each platform has unique propert...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319310005

    authors: Hofbauer A,Stoger E

    更新日期:2013-01-01 00:00:00

  • The Relevance of Dietary Polyphenols in Cardiovascular Protection.

    abstract::The chemical structure of polyphenols consisting of aromatic rings, capable of quenching free radicals, makes them ideal candidates to protect against oxidation. Polyphenols are present in a variety of foods including grapes, berries, dark chocolate, coffee and tea to mention a few. A number of studies have shown that...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170329144307

    authors: Murillo AG,Fernandez ML

    更新日期:2017-01-01 00:00:00

  • Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.

    abstract::In the early 1980s, an "atypical" beta-adrenergic receptor was discovered and subsequently called the beta (3)-adrenoceptor (beta(3)-AR). Agonists of the beta(3)-AR were observed to simultaneously increase lipolysis, fat oxidation, energy expenditure and insulin action leading to the belief that this receptor might se...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013397339

    authors: de Souza CJ,Burkey BF

    更新日期:2001-09-01 00:00:00

  • Clopidogrel resistance: implications for coronary stenting.

    abstract::Clopidogrel, in combination wih aspirin, is currently the drug of choice to prevent thrombosis after coronary stent implantation. Currently, clopidogrel is administered to the vast majority of patients without any assessment of platelet inhibition. Response variability and resistance, however, definitely occur to clop...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776361345

    authors: Gurbel PA,Lau WC,Bliden KP,Tantry US

    更新日期:2006-01-01 00:00:00

  • Can mycobacterial genomics generate novel targets as speed-breakers against the race for drug resistance.

    abstract::The rise of multi-drug resistant and extensively drug resistant M. tuberculosis around the world poses a great threat to human health, and necessitates development of new, effective and inexpensive anti-tubercular agents. The availability of knowledge on molecular biology of M. tuberculosis infection coupled with whol...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612819666131118165427

    authors: Chauhan RS,Chanumolu SK,Rout C,Shrivastava R

    更新日期:2014-01-01 00:00:00

  • Rationale for new drugs targeting the tissue microenvironment in patients with HCC.

    abstract::A better knowledge of the mechanisms underlying hepatocellular carcinoma (HCC) growth and spread is essential to improve the available treatment options. So far, the only therapies available for HCC are mainly based on tumor-destructive approaches, whereas no therapies are available to consolidate these invasive thera...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207782360645

    authors: Antonaci S,Giannelli G

    更新日期:2007-01-01 00:00:00

  • Using nanotechnology to design potential therapies for CNS regeneration.

    abstract::The nanodelivery of therapeutics into the brain will require a step-change in thinking; overcoming the blood brain barrier is one of the major challenges to any neural therapy. The promise of nanotechnology is that the selective delivery of therapeutics can be delivered through to the brain without causing secondary d...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207781368648

    authors: Ellis-Behnke RG,Teather LA,Schneider GE,So KF

    更新日期:2007-01-01 00:00:00

  • Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.

    abstract::Drug discovery is generally considered as a costly affair and it takes approximately 15 years to reach a new chemical entity into the market. Among the recent potent drug molecules with most effective pharmacological properties, very few reached for Phase I clinical trial in humans. Unfortunately, the historical avera...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190618121553

    authors: Paudwal G,Rawat N,Gupta R,Baldi A,Singh G,Gupta PN

    更新日期:2019-01-01 00:00:00

  • AMPA receptor antagonists with additional mechanisms of action: new opportunities for neuroprotective drugs?

    abstract::Ischaemic stroke of the brain accounts for about one third of all deaths in industrialized countries. Many of the patients who survive are severily impaired. Thus, there is an enormous need for pharmacotherapy for the treatment of ischaemic stroke. Why is such a treatment not available yet? Are the pathophysiological ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612024607135

    authors: Weiser T

    更新日期:2002-01-01 00:00:00

  • RNAi in Plasmodium.

    abstract::RNA interference (RNAi) has quickly proven to be an immensely useful tool for studying gene function and validation of potential drug targets in almost all organisms that possess the required set of proteins of the interference pathway. In protozoan parasites like Plasmodium, Toxoplasma, Entamoeba, Giardia, Trypanosom...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990027

    authors: Mueller AK,Hammerschmidt-Kamper C,Kaiser A

    更新日期:2014-01-01 00:00:00

  • Systemic Allergy to Corticosteroids: Clinical Features and Cross Reactivity.

    abstract::Systemic hypersensitivity (HS) to corticosteroids (CS) is paradoxical but does exist. Some patients with a previous contact allergy to topical CS may develop a systemic contact dermatitis (SCD) while receiving CS orally or intravenously. However, a previous contact sensitization is not mandatory for developing a syste...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161013092339

    authors: Barbaud A,Waton J

    更新日期:2016-01-01 00:00:00

  • Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factors.

    abstract::Human arylamine N-acetyltransferases 1 and 2 (NAT1 and NAT2) are polymorphic phase II xenobiotic-metabolising enzymes (XME) that acetylate arylamine compounds. They therefore play an important role in the detoxication and/or metabolic activation of certain therapeutic drugs, occupational chemicals and carcinogens. Alt...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043383845

    authors: Rodrigues-Lima F,Dupret JM

    更新日期:2004-01-01 00:00:00

  • Raloxifene and cardiovascular health: its relationship to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women.

    abstract::CHD is one of the most common serious chronic conditions in postmenopausal women and leads to extremely high risk for recurrent myocardial infarction and death. On the basis of the currently available randomized clinical-trial results the role of conventional HRT for treatment and prevention of CHD is rapidly evolving...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774913237

    authors: Francucci CM,Camilletti A,Boscaro M

    更新日期:2005-01-01 00:00:00

  • Phytoestrogen genistein and its pharmacological interactions with synthetic endocrine-active compounds.

    abstract::Phytoestrogens are plant-derived compounds with estrogen-like activities. Certain foods such as soy-derived products are known to have high levels of phytoestrogens, and about 25% of commercial infant formulas used in the United States are soy-based. One of the most important phytoestrogens is the isoflavone genistein...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043383683

    authors: You L

    更新日期:2004-01-01 00:00:00

  • The Contribution of Transcriptomics to Biomarker Development in Systemic Vasculitis and SLE.

    abstract::A small but increasing number of gene expression based biomarkers are becoming available for routine clinical use, principally in oncology and transplantation. These underscore the potential of gene expression arrays and RNA sequencing for biomarker development, but this potential has not yet been fully realized and m...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150313130256

    authors: Flint SM,McKinney EF,Lyons PA,Smith KG

    更新日期:2015-01-01 00:00:00

  • SERMs: evolutionary chemistry, revolutionary biology.

    abstract::Estrogens are known as important modulators of development, growth and maintenance of primary sexual physiology. The medical field has also grown increasingly appreciative of the effects of estrogens on non-traditional target tissues such as bone, cardiovascular tissue and the CNS. Postmenopausal women have been the b...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023393404

    authors: Miller CP

    更新日期:2002-01-01 00:00:00

  • Towards histone deacetylase inhibitors as new antimalarial drugs.

    abstract::Histone deacetylases (HDACs) are important enzymes that effect post-translational modifications of proteins by altering the acetylation state of lysine residues. HDACs control epigenetic changes that trigger cell transformation and proliferation of transformed cells associated with many diseases. These enzymes are val...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Andrews KT,Tran TN,Fairlie DP

    更新日期:2012-01-01 00:00:00

  • Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data.

    abstract::Among pediatric patients, preterm neonates and newborns are the most vulnerable subpopulation. Rapid developmental changes of physiological factors affecting the pharmacokinetics of drug substances in newborns require extreme care in dose and dose regimen decisions. These decisions could be supported by in silico meth...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150901110533

    authors: Claassen K,Thelen K,Coboeken K,Gaub T,Lippert J,Allegaert K,Willmann S

    更新日期:2015-01-01 00:00:00

  • Targeting RANK/RANKL in the treatment of solid tumours and myeloma.

    abstract::Cancers which damage the human skeleton include multiple myeloma, where the primary tumour colonises bone directly, or breast and prostate cancer, where malignant cells travel from the primary tumour to form clonal outgrowths within the bone. Owing to the interaction of tumour cells with those normally found in the bo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210791034021

    authors: Buckle CH,Neville-Webbe HL,Croucher PI,Lawson MA

    更新日期:2010-01-01 00:00:00

  • Strategies for skeletal muscle targeting in drug discovery.

    abstract::The targeting of drugs to skeletal muscle is an emerging area of research. Driven by the need for new therapies to treat a range of muscle-associated diseases, these strategies aim to provide improved drug exposure at the site of action in skeletal muscle with reduced concentration in other tissues where unwanted side...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140929095755

    authors: Ebner DC,Bialek P,El-Kattan AF,Ambler CM,Tu M

    更新日期:2015-01-01 00:00:00

  • The roles of phosphodiesterase 2 in the central nervous and peripheral systems.

    abstract::Phosphodiesterase 2 (PDE2) is a ubiquitous enzyme whose major role is to hydrolyze the important second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). In the central nervous system, pharmacological inhibition of PDE2 results in boosted cAMP and/or cGMP signaling, which is r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140826115245

    authors: Zhang C,Yu Y,Ruan L,Wang C,Pan J,Klabnik J,Lueptow L,Zhang HT,O'Donnell JM,Xu Y

    更新日期:2015-01-01 00:00:00

  • Molecular mapping in the CNS.

    abstract::Since ancient times the operation of the brain has elicited more than usual interest. Data mining of the human genome is revealing that many CNS abnormalities have a genetic component. As yet this information can not be used directly to cure or ameliorate specific CNS disorders although this is regarded as having grea...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612023394250

    authors: Wong MG,Tehan BG,Lloyd EJ

    更新日期:2002-01-01 00:00:00

  • NAP (davunetide) provides functional and structural neuroprotection.

    abstract::NAP (davunetide) is an eight amino acid peptide (NAPVSIPQ) that has been shown to provide potent neuroprotection, in vitro and in vivo. In human clinical trials, NAP has been shown to increase memory scores in patients suffering from amnestic mild cognitive impairment, a precursor to Alzheimer's disease and to enhance...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795589373

    authors: Gozes I

    更新日期:2011-01-01 00:00:00

  • Do substance P and the NK1 receptor have a role in depression and anxiety?

    abstract::Research on Substance P (SP) has, until recently, focused on its role in pain and inflammation. However, a report that NK(1) receptor antagonists have utility in the treatment of depression has stimulated research into the function of SP and the NK(1)receptor in anxiety and depression. The distribution of SP and the N...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612053764779

    authors: McLean S

    更新日期:2005-01-01 00:00:00

  • Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?

    abstract::Hyperferritinemia is observed in one-third of patients with non-alcoholic fatty liver disease (NAFLD) and Metabolic Syndrome (MetS). The condition characterized by increased body iron stores associated with components of MetS has been defined as Dysmetabolic Iron Overload Syndrome (DIOS). DIOS represents the most freq...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200131103018

    authors: Rametta R,Fracanzani AL,Fargion S,Dongiovanni P

    更新日期:2020-01-01 00:00:00